"Eli Lilly Revolutionizes Weight-Loss Treatment with Direct-to-Consumer Drug Delivery and Telehealth Services"
WW International, known as WeightWatchers, saw its shares drop significantly after Eli Lilly launched a digital platform, LillyDirect, to deliver weight-loss drugs, which directly competes with WeightWatchers' market. Despite the decline, analysts believe WW's strong brand could still thrive in the weight-loss space. Other companies in the online prescription weight-loss market also experienced share price declines following the announcement.